Musical Compositions Sample Clauses

The 'Musical Compositions' clause defines the rights and obligations related to the use, ownership, or licensing of musical works within an agreement. It typically specifies which party holds the copyright to the compositions, outlines permissions for use or performance, and may address royalties or revenue sharing from exploitation of the music. This clause ensures that all parties clearly understand their rights regarding musical content, thereby preventing disputes over ownership or usage and facilitating smooth collaboration or distribution.
POPULAR SAMPLE Copied 1 times
Musical Compositions. WWFE represents that the performing rights in the music contained in each Program are controlled by BMI, ASCAP, SESAC, or any other performing rights society having jurisdiction, are in the public domain, or are controlled by WWFE to the extent necessary to permit UPN's use of each Program in accordance with this Agreement. WWFE shall indemnify UPN regarding any residual royalties or any other payments required to be made in connection with any of the music used in any of the Programs.
View Source
Musical Compositions. 23 8.4 Procedure.....................................................................................23 9. TERMINATION............................................................................................23
View SourceView Similar (3)
Musical Compositions. Licensor warrants and represents that to the best of its knowledge, information and belief, the performing rights in all musical compositions contained in the Licensed Programming are: (i) controlled by a performing rights society having jurisdiction, (ii) controlled by Licensor, or (iii) in the public domain. Licensor does not represent or warrant that the Company may exercise the performing rights to said musical compositions without the payment of a performing rights royalty. The Company will be solely responsible for the payment of such royalty and will hold Licensor free and harmless therefrom.
View SourceView Similar (7)
Musical Compositions. WWFE represents that the performing rights in the music contained in each Program are controlled by BMI, ASCAP, SESAC, or any other performing rights society having jurisdiction, are in the public domain, or are controlled by WWFE to the extent necessary to permit UPN's use of each Program in accordance with this Agreement. WWFE shall indemnify UPN regarding any residual royalties or any other payments required to be made in connection with any of the music used in any of the Programs. CONFIDENTIAL TREATMENT *****[Deleted pursuant to a request for Confidential Treatment and filed separately with the Securities and Exchange Commission]
View Source
Musical Compositions. You shall not record or deliver hereunder nor shall we be obligated to accept Masters constituting a Multiple Album. If, however, you shall do so and we shall accept those Masters hereunder, then, at our election, for the purpose of calculating the number of Masters recorded and delivered hereunder, those Masters shall be deemed to constitute only one (1) Album;
View SourceView Similar (4)
Musical Compositions. 20 7.4 Procedure.................................................20 7.5 Taxes.....................................................21
View SourceView Similar (3)
Musical Compositions. ("Songs") All songs or material recorded on the Masters recorded hereunder which are written or composed by Producer, in whole or in part, alone or in collaboration with Artist or with others employed by Artist, shall be considered a work made for hire for Employer. If any such song, collaboration or other material are determined not to be a work made for hire, all copyrights in the song or added material which is attributable to the Producer's participation in its authorship will be deemed transferred to Employer by this Agreement. All such songs or material recorded under this Agreement, from the inception of recording, shall be the sole property of Employer, free from any claims whatsoever by Producer or any other person; and Employer shall have the exclusive right to claim copyright in those songs or collaborations in Artist's name as the owner and author of them and to secure any and all renewals and extensions of such copyright throughout the world.
View Source
Musical Compositions and Digital Fixations shall at all times remain the property of the Owner.
View Source
Musical Compositions. (i) Except to the extent specifically set forth and identified on Schedule 4.20(e)(i), (A) Seller or a Transferred Subsidiary is, and as of the Closing Date a Transferred Subsidiary will be, the sole and exclusive owner or licensee of its respective share of all right, title and interest in and to the Compositions, including the lyrics and music thereof and all other rights in and to the Compositions, and all claims and demands accrued or to accrue with respect to the Compositions, and the copyrights and the future contingent renewal and extended terms of copyrights in and to the Compositions, and all rights to secure renewals and extensions of copyright, throughout the world, (B) (other than royalty obligations of Seller under any “Songwriter Agreements” (as defined in Section 4.20(e)(ii) below)), no person or business entity other than Seller or a Transferred Subsidiary has or as of the Closing Date will have, or may validly claim, a proprietary, administrative or participatory interest in any Composition, and (C) Seller or a Transferred Subsidiary has a good and marketable interest in and to the Compositions (to the extent of its respective percentage interest reflected on Schedule 4.20(e)(i)), and no such interest has been assigned, pledged or otherwise transferred or encumbered, other than Permitted Exceptions. With respect to each instance in which a right or interest is marked on Schedule 4.20(e)(i) as “unsettled,” all reasons for such designation are listed on said Schedule 4.20(e)(i) and there exist no other reasons for such designation. (ii) (A) Except to the extent specifically set forth and identified on Schedule 4.20(e)(i) (including but not limited to those Compositions for which Schedule 4.20(e)(i) indicates agreements are missing), all of the grants of rights and conveyances contained in the agreements or other instruments of transfer between Seller (or any predecessor of Seller) and the writers and composers of the Compositions (hereinafter sometimes referred to as the “Songwriters”), and between Seller (or any predecessor of Seller) and publishers or other grantors from whom Seller (or any predecessor of Seller) acquired rights in the Compositions (“Grantors”), are in full force and effect (all such agreements with Songwriters and Grantors, “Songwriter Agreements”).
View Source

Related to Musical Compositions

  • Licensed Technology (a) LICENSOR is not aware of any interference, infringement, misappropriation, or other conflict with any intellectual property rights of third parties, and LICENSOR has never received any charge, complaint, claim, demand, or notice alleging any such interference, infringement, misappropriation, or violation (including any claim that LICENSOR must license or refrain from using any intellectual property rights of any third party). To the knowledge of LICENSOR, no third party has interfered with, infringed upon, misappropriated, or otherwise come into conflict with any of the LICENSED TECHNOLOGY. (b) Exhibit A identifies each patent or registration which has been issued to LICENSOR with respect to any of the LICENSED TECHNOLOGY and identifies each pending patent application or application for registration which LICENSOR has made with respect to any of the LICENSED TECHNOLOGY. LICENSEE acknowledges that LICENSOR has previously made available to LICENSEE correct and complete copies of all such patents, registrations and applications (as amended to-date) in LICENSOR’s possession and has made available to LICENSEE correct and complete copies of all other written documentation in LICENSOR’s possession evidencing ownership and prosecution (if applicable) of each such item. (c) Exhibit A identifies each item of LICENSED TECHNOLOGY that is assigned to LICENSOR or that LICENSOR uses pursuant to license, sublicense, agreement, or permission. LICENSOR has made available to LICENSEE correct and complete copies of all such licenses, sublicenses, agreements, patent prosecution files and permissions (as amended to-date) in LICENSOR’s possession. With respect to each item of LICENSED TECHNOLOGY required to be identified in Exhibit A and to the knowledge of LICENSOR: (i) the license, sublicense, agreement, or permission covering the item is legal, valid, binding, enforceable, and in full force and effect; (ii) the license, sublicense, agreement, or permission will continue to be legal, valid, binding, enforceable, and in full force and effect on identical terms following the consummation of the transactions contemplated hereby; (iii) no Party to the license, sublicense, agreement, or permission is in breach or default, and no event has occurred which with notice or lapse of time would constitute a breach or default or permit termination, modification, or acceleration thereunder; (iv) no party to the license, sublicense, agreement, or permission has repudiated any provision thereof; (v) the underlying item of LICENSED TECHNOLOGY is not subject to any outstanding lien or encumbrance, injunction, judgment, order, decree, ruling, or charge; (vi) no action, suit, proceeding, hearing, investigation, charge, complaint, claim, or demand is pending or is threatened which challenges the legality, validity, or enforceability of the underlying item of LICENSED TECHNOLOGY; and (vii) except as provided in Exhibit A, LICENSOR has not granted any license or similar right to the LICENSED TECHNOLOGY within the GENERAL FIELD or PARTHENOGENESIS FIELD.

  • Licensed Patents Immune Design, at its expense, shall have the first right to file, prosecute and maintain all Licensed Patents for which Immune Design has any exclusive rights under this Agreement using patent counsel reasonably approved by IDRI, including conducting any interferences, reexaminations, reissues, oppositions, or request for patent term extension relating thereto. Immune Design shall conduct such filing, prosecution and maintenance in good faith, taking into consideration IDRI’s retained rights hereunder, and consistent with reasonable business judgment, provide IDRI with all relevant or material documentation and proposed filing in the Territory so that IDRI may be concurrently and promptly informed of the continuing prosecution, and consult with IDRI with regards to Immune Design’s patent strategy with the Licensed Patents for which Immune Design has any exclusive rights under this Agreement. Licensed Patents in the name of IDRI shall remain in the name of IDRI. Immune Design shall use commercially reasonable efforts to ***, as applicable. To the extent such ***, Immune Design shall provide IDRI reasonable opportunity to review and comment on such prosecution efforts regarding such Licensed Patents in the Territory, and any IDRI comments will be reasonably considered in such prosecution efforts, and included to the extent affecting the IDRI Exclusive Field or IDRI Territory, as the case may be. If Immune Design determines in its sole discretion to abandon or not maintain any Licensed Patent for which Immune Design has any exclusive rights under this Agreement in the Territory, then Immune Design shall promptly provide IDRI with written notice of such determination at least sixty (60) days before any deadline for taking action to avoid abandonment and shall provide IDRI with the right, opportunity and reasonable assistance to prepare, file, prosecute and maintain such Licensed Patent in the applicable jurisdiction in IDRI’s sole discretion and at IDRI’s expense, provided that Immune Design shall provide such reasonable assistance at its own costs and expenses. If IDRI elects to prepare, file, prosecute and maintain such Licensed Patent in such jurisdiction for which Immune Design has any exclusive rights, then Immune Design’s license rights to such Licensed Patent in such country will become nonexclusive in such country under such Licensed Patent (and/or patent application). If IDRI desires Immune Design to file, in a particular jurisdiction, a Licensed Patent for which Immune Design has any exclusive rights under this Agreement that claims priority to another Licensed Patent for which Immune Design has any exclusive rights under this Agreement, IDRI shall provide written notice to Immune Design requesting that Immune Design file such patent application in such jurisdiction. If IDRI provides such written notice to Immune Design, Immune Design shall either (i) file and prosecute such patent application and maintain any patent issuing thereon in such jurisdiction and the Parties shall share the related costs and expenses (A) in countries *** on the basis of *** percent (***%) Immune Design: *** percent (***%) IDRI or (B) in countries within the IDRI Territory equally; or (ii) notify IDRI that Immune Design does not desire to file such patent application in such jurisdiction and provide IDRI with the opportunity to file and prosecute such patent application, provided that if IDRI files and prosecutes such patent application in such jurisdiction, then Immune Design’s license rights to such License Patent in such country will become nonexclusive in such country under such Licensed GLA Patent (and/or patent application). Immune Design shall be responsible for the costs and expenses incurred in connection with its own activities for filing, prosecuting and maintaining the Licensed Patents; IDRI shall be responsible for monitoring of such activities by IDRI.

  • Research Use The Requester agrees that if access is approved, (1) the PI named in the DAR and (2) those named in the “Senior/Key Person Profile” section of the DAR, including the Information Technology Director and any trainee, employee, or contractor1 working on the proposed research project under the direct oversight of these individuals, shall become Approved Users of the requested dataset(s). Research use will occur solely in connection with the approved research project described in the DAR, which includes a 1-2 paragraph description of the proposed research (i.e., a Research Use Statement). Investigators interested in using Cloud Computing for data storage and analysis must request permission to use Cloud Computing in the DAR and identify the Cloud Service Provider (CSP) or providers and/or Private Cloud System (PCS) that they propose to use. They must also submit a Cloud Computing Use Statement as part of the DAR that describes the type of service and how it will be used to carry out the proposed research as described in the Research Use Statement. If the Approved Users plan to collaborate with investigators outside the Requester, the investigators at each external site must submit an independent DAR using the same project title and Research Use Statement, and if using the cloud, Cloud Computing Use Statement. New uses of these data outside those described in the DAR will require submission of a new DAR; modifications to the research project will require submission of an amendment to this application (e.g., adding or deleting Requester Collaborators from the Requester, adding datasets to an approved project). Access to the requested dataset(s) is granted for a period of one (1) year, with the option to renew access or close-out a project at the end of that year. Submitting Investigator(s), or their collaborators, who provided the data or samples used to generate controlled-access datasets subject to the NIH GDS Policy and who have Institutional Review Board (IRB) approval and who meet any other study specific terms of access, are exempt from the limitation on the scope of the research use as defined in the DAR.

  • Patent Applications It is understood by the parties that, pursuant to the Baylor Technology Transfer Agreement, MAS has the initial responsibility for filing, prosecution and maintenance of Patents and Patent Applications covering the Baylor Technology. The parties agree that, as between MAS and IllumeSys, MAS shall be responsible for deciding whether and how to file, prosecute and maintain the Patents and Patent Applications, provided that:

  • Copyrightable Works Contractor must notify the Customer and the Department of any publications, artwork, or other copyrightable works developed in connection with the Customer’s contract. All copyrights created or developed through performance of the Customer’s contract are owned solely by the State of Florida. This shall not apply to any copyrightable works created or developed prior to the execution of the Term Contract.